Iran vs MENA Programme Region: Percentage of surviving infants who received … DTP-containing
Iran
98
in 2025
MENA Programme Region
83
in 2025
Iran rank
3rd
MENA Programme Region rank
2nd
Percentage of surviving infants who received … DTP-containing over time
- Iran
- MENA Programme Region
How they compare
Iran currently reports 98 against 83 in MENA Programme Region, a difference of 15.
That makes Iran's figure about 1.2 times MENA Programme Region's.
The two have swapped places 4 times across 46 shared years of data; in 1980 it was Iran ahead.
Iran ranks 3rd and MENA Programme Region ranks 2nd of 20 countries.
Iran has averaged higher in every one of the 5 decades both report.
Head to head by decade
| Decade | Iran | MENA Programme Region | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 50.3 | 49 | 1.3 | Iran |
| 1990s | 96.4 | 80.8 | 15.6 | Iran |
| 2000s | 98.2 | 87.6 | 10.6 | Iran |
| 2010s | 98.8 | 89.5 | 9.3 | Iran |
| 2020s | 98.5 | 83.17 | 15.33 | Iran |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of surviving infants who received the third dose of, Iran or MENA Programme Region?
- Iran, at 98 against 83 in MENA Programme Region as of 2025.
- What is the difference in percentage of surviving infants who received the third dose of between Iran and MENA Programme Region?
- 15, with Iran ahead.
- How many years of comparable data are there for Iran and MENA Programme Region?
- 46 years are reported by both, from 1980 to 2025.
- How do Iran and MENA Programme Region rank globally for percentage of surviving infants who received the third dose of?
- Iran ranks 3rd and MENA Programme Region ranks 2nd of 20 countries.
- Where does this data come from?
- UNICEF, published as Percentage of surviving infants who received the third dose of DTP-containing vaccine. Statizoid refreshes it automatically from the source and publishes the full history for both places.